Search Beyond News…

Court-approved Skin360 class action settlement notifies Illinois users of potential cash payouts for assessments conducted between 2019 and 2023

Executive summary: The settlement administrator released a court‑authorized notice stating that individuals who performed a Skin360 skin assessment via a mobile or web application in Illinois between December 9, 2019 and May 5, 2023 may be eligible for cash payments from the Helene Melzer class action settlement. It signals potential financial relief for thousands of consumers and underscores continued regulatory attention to data practices and claims made by skin‑analysis mobile apps.

Who is involved: Plaintiffs Helene Melzer et al.; defendant Johnson & Johnson Consumer Inc.; the court‑approved Settlement Administrator; the U.S. District Court for the District of New Jersey; Illinois residents who used Neutrogena® or NeoStrata® Skin360® apps.

Likely next: Eligible users will need to submit claims by the deadline set in the settlement; the administrator will review submissions and distribute approved payments.

The settlement administrator issued a court‑authorized notice informing anyone who used a Skin360 skin‑analysis app (including Neutrogena® and NeoStrata® versions) in Illinois from December 9, 2019 to May 5, 2023 that they may be entitled to a cash payment from the Helene Melzer et al. v. Johnson & Johnson Consumer Inc. settlement. The notice outlines eligibility criteria and directs potential claimants to the administrator for further instructions. This development highlights ongoing consumer‑protection scrutiny of mobile health‑app services and could result in financial compensation for thousands of users.

What's next — scenarios

Base Case: Standard Claim Payout and Quiet Closure (65%)

Johnson & Johnson absorbs the agreed settlement payout without significant additional regulatory penalties, closing the litigation chapter for the 2019–2023 period.

Downside: Multi-State Copycat Litigation (20%)

Consumer advocacy groups and plaintiff law firms launch similar biometric privacy class actions in states with laws comparable to Illinois' BIPA.

Upside: Precedent-Setting Dismissal of Future Claims (15%)

The settlement terms successfully establish a legal framework that shields similar AR/AI beauty tech features from future liability, lowering compliance risks for future product rollouts.

What to watch

Timeline

Analysis — what this means

Sectors affected

Historical parallels

Key entities

Sources

Related cases

Browse the full archive →